Gemcitabine plus oxaliplatin vs 5‐fluorouracil plus cisplatin plus radiotherapy
Serious adverse events · people with advanced biliary tract carcinomas
It is very uncertain whether gemcitabine plus oxaliplatin changes serious adverse events compared with 5‐fluorouracil plus cisplatin plus radiotherapy (very low certainty).
1 finding from 1 review
- Gemcitabine‐based chemotherapy for advanced biliary tract carcinomas 2018 · Cochrane Headline outcomes onlyRR 1.5 [0.66, 3.39]1 study · 34 participantsVery low